qa_id stringlengths 27 27 | qa_group_id stringlengths 28 32 | qa_family stringclasses 3
values | subtask_type stringclasses 7
values | qa_subtype stringclasses 3
values | cluster_id stringclasses 42
values | language stringclasses 1
value | split stringclasses 1
value | question stringlengths 148 1.41k | answer stringlengths 718 10.8k | claim_ids listlengths 0 8 | paper_ids listlengths 1 5 | evidence_span_ids listlengths 0 7 | association_ids listlengths 0 4 | hypothesis_ids listlengths 0 4 | record_json stringlengths 4.37k 33.7k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QA:0369010957355e67c767a944 | QAG:9d9c7e6616bfd8c9ee3eb874 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "We discovered that drug responsiveness increased in the M-ORG medium in the oxaliplatin-sensitive CRC group ( Figure 5 A–C)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting p... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8cb2f0e289fce932d58a2d7c","quotes":["We discovered that drug responsiveness increased in the M-ORG medium in the ... | [
"CLM:8cb2f0e289fce932d58a2d7c",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:cce6f668b6ce3211a6c40bb2"
] | [] | [] | {"qa_id":"QA:0369010957355e67c767a944","qa_group_id":"QAG:9d9c7e6616bfd8c9ee3eb874","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"We discovered that drug responsiveness increased in the M-ORG medi... |
QA:05acc3a2c623680e3b36910a | QAG:bfb2eaa8cb590072ae33d03c | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived organoids predicted chemoradiation responses of locally advanced rectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:36f0a2fc82a23eecf6424f55","quotes":["Patient-derived organoids predict chemoradiatio... | [
"CLM_SUP:36f0a2fc82a23eecf6424f55",
"CLM:1cac52e2cbd154d19265a10b",
"CLM:964599b1ed749bd860036142"
] | [
"PMCID:PMC10072204",
"PMCID:PMC5127645"
] | [
"SPAN_SUP:f653115bb6cb7c3ee616e90c",
"SPAN:7ea72f4e959671bb7008971e"
] | [
"ASC2:457b392264c1ee5fe8ba795f"
] | [
"HYP:DCH:631f65adbddef0d87bc9f851"
] | {"qa_id":"QA:05acc3a2c623680e3b36910a","qa_group_id":"QAG:bfb2eaa8cb590072ae33d03c","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived organoids predicted chemoradiation responses of lo... |
QA:06de69753ce53d55ed17577f | QAG:3c9eedf8da6b612d1b53f8e2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "PDOs test predicted the response to biopsy lesions in more than 80% of patients treated with irinotecan in metastatic CRC patients, without misclassifying patients who would have benefited from this treatment"? Return the original wording with paper, Claim, and Evidenc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:eae825b05f201e17d6ce537b","quotes":["PDOs test predicted the response to biopsy lesions in more than 80% of patie... | [
"CLM:eae825b05f201e17d6ce537b",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:a57b891b9b2d5b86cfc41318"
] | [] | [] | {"qa_id":"QA:06de69753ce53d55ed17577f","qa_group_id":"QAG:3c9eedf8da6b612d1b53f8e2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"PDOs test predicted the response to biopsy lesions in more than 80... |
QA:0745a0cd175769e1810c62ea | QAG:b45319e462cc39d4a41b051a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Seeded cells were synchronized overnight by serum starvation to reduce the FBXW7 deficiency promoted cell division/growth in CRC cells, as reported previously, 23 , 24 , 30 , 32 , 35 prior to 72 hours incubation with 5-FU for cytotoxicity assay"? Return the original wo... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:85a497a886e069c071ddd7b2","quotes":["Seeded cells were synchronized overnight by serum starvation to reduce the F... | [
"CLM:85a497a886e069c071ddd7b2",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:93201cc503ec7771791773ac"
] | [] | [] | {"qa_id":"QA:0745a0cd175769e1810c62ea","qa_group_id":"QAG:b45319e462cc39d4a41b051a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Seeded cells were synchronized overnight by serum starvation to re... |
QA:095a66638dfeee9077c6baaa | QAG:c87b8754770377bf7a565071 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9208081? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9208081","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9208081"
] | [] | [] | [] | {"qa_id":"QA:095a66638dfeee9077c6baaa","qa_group_id":"QAG:c87b8754770377bf7a565071","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9208081... |
QA:09bde148b9d858a5334a2ed2 | QAG:93700f3bed04af74dbf01179 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "5-Fluorouracil promoted apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-δ"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact sup... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:213dcff62e2f84aa96d1c1e5","quotes":["5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dep... | [
"CLM:213dcff62e2f84aa96d1c1e5",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:759eda6682dc89e7515d2ca7"
] | [] | [] | {"qa_id":"QA:09bde148b9d858a5334a2ed2","qa_group_id":"QAG:93700f3bed04af74dbf01179","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"5-Fluorouracil promoted apoptosis in colorectal cancer cells is ca... |
QA:0b5bc4d10158d84101eb55ae | QAG:435e96a8441a9ae92bee2c13 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35273398? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35273398","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35273398"
] | [] | [] | [] | {"qa_id":"QA:0b5bc4d10158d84101eb55ae","qa_group_id":"QAG:435e96a8441a9ae92bee2c13","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35273398? E... |
QA:0c38578831052ac953469370 | QAG:7a0925a01b7c443983c06eb7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Tumor tissue resections from colorectal cancer (CRC) patients were received from the USC Norris Comprehensive Cancer Center following institutional review board (IRB) approval and patient consent"? Return the original wording with paper, Claim, and Evidence Span refere... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c025d05547161c3dee3e91c9","quotes":["Tumor tissue resections from colorectal cancer (CRC) patients were received ... | [
"CLM:c025d05547161c3dee3e91c9",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC7372585"
] | [
"SPAN:7408344188f317756a113a1a"
] | [] | [] | {"qa_id":"QA:0c38578831052ac953469370","qa_group_id":"QAG:7a0925a01b7c443983c06eb7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Tumor tissue resections from colorectal cancer (CRC) patients were... |
QA:0dafe9f1e42183ef9d02cdad | QAG:532a32ec282bc6fff19288d4 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8903172? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC8903172","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC8903172"
] | [] | [] | [] | {"qa_id":"QA:0dafe9f1e42183ef9d02cdad","qa_group_id":"QAG:532a32ec282bc6fff19288d4","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8903172... |
QA:12dbfa8372a09f6dafcc5bad | QAG:037d58a083c96a5f1acf526b | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "PATIENTS: A total of 108 patients who underwent surgery with successful patient-derived tumor organoid culture and drug testing were enrolled between June 2018 and June 2019. INTERVENTIONS: Patient-derived tumor organoid culture and chemotherapeutic drug testing"? Retu... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:de80640f7bcbdd26270d1cbb","quotes":["PATIENTS: A total of 108 p... | [
"CLM:de80640f7bcbdd26270d1cbb",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:e49826e9ab803ef3c982098b",
"CLM:ee5340e77d50a52ad1902b72"
] | [
"PMCID:PMC10072204",
"PMID:34633791",
"PMCID:PMC9863259"
] | [
"SPAN:44b65ae26b7b6d719b839cce",
"SPAN:7f5296582c2e59daed2d4772",
"SPAN:6e27e2e60d22b7d4b15d64e0",
"SPAN:dd4b077cd77906823659ea2d",
"SPAN:e626c91e06fc2cbaeb2f2891"
] | [
"ASC2:d530f59f45c88db6c33230f3",
"ASC2:8e6b6761cba63bc6a3878b30"
] | [
"HYP:DCH:b4a16b911d00e03d9ff282d8",
"HYP:DCH:9a3403d9d44269d3ef8198f5"
] | {"qa_id":"QA:12dbfa8372a09f6dafcc5bad","qa_group_id":"QAG:037d58a083c96a5f1acf526b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"PATIENTS: A total of 108 patients who underwent surgery with succe... |
QA:21b6b92df51e401c98db8a55 | QAG:314dce1c6859e790c9e00227 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "There is an urgent need to develop new therapies for colorectal cancer that has metastasized to the liver and, more fundamentally, to develop improved preclinical platforms of colorectal cancer liver metastases (CRCLM) to screen therapies for efficacy"? Return the orig... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:646721b4e027fe64af27af32","quotes":["There is an urgent need to develop new therapies for colorectal cancer that ... | [
"CLM:646721b4e027fe64af27af32",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10264793"
] | [
"SPAN:069d94c498bed9eded6ac62c"
] | [] | [] | {"qa_id":"QA:21b6b92df51e401c98db8a55","qa_group_id":"QAG:314dce1c6859e790c9e00227","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"There is an urgent need to develop new therapies for colorectal ca... |
QA:22b9c324f2107b94ee40e4e1 | QAG:ab9b7b1f6e2c79b7345e9152 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "18 However, we find Berzosertib only increases SN-38 promoted apoptosis in microsatellite unstable (MSI) PDOs ( Fig- ure S5 I), suggesting ATR inhibitors might only be effective in MSI CRC patients"? Return the original wording with paper, Claim, and Evidence Span refer... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:02ff8ab5ecc9755da71f1be3","quotes":["18 However, we find Berzosertib only increases SN-38-\ninduced apoptosis in m... | [
"CLM:02ff8ab5ecc9755da71f1be3",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMID:38065081"
] | [
"SPAN:76e382b6021b1b7953bb1a83"
] | [] | [] | {"qa_id":"QA:22b9c324f2107b94ee40e4e1","qa_group_id":"QAG:ab9b7b1f6e2c79b7345e9152","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"18 However, we find Berzosertib only increases SN-38 promoted apopt... |
QA:2584454a7d499920d989d38b | QAG:5a84158c5c32140589afdfb8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "24 , 25 , 28 In vitro studies also reported that loss of FBXW7 function led to the acquisition of drug resistance in CRC cell lines, through the induction of an epithelial-mesenchymal transition (EMT) pathway, 32 and/or alteration of MCL1, 40 mTOR, 41 and TP53 status"?... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:947232baf5a32fd4cad7ed82","quotes":["24 , 25 , 28 In vitro studies also reported that loss of FBXW7 function lead... | [
"CLM:947232baf5a32fd4cad7ed82",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:4d6c6cd5eee8b08fa0ed5a7c"
] | [] | [] | {"qa_id":"QA:2584454a7d499920d989d38b","qa_group_id":"QAG:5a84158c5c32140589afdfb8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"24 , 25 , 28 In vitro studies also reported that loss of FBXW7 fun... |
QA:265e3805696199cb0d34d7cc | QAG:aa6a3e9794811e565c6678cc | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Multivariate Cox analysis disclosed that 46 of 77 DRGs’ expression levels was correlated with the survival of CRCpts in TCGA-CRC dataset ( Table S6 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ret... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:afc47b1b49c98ec924266338","quotes":["Multivariate Cox analysis disclosed that 46 of 77 DRGs’ expression levels we... | [
"CLM:afc47b1b49c98ec924266338",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC9004628"
] | [
"SPAN:d1da9415e4ec61af22288e42"
] | [] | [] | {"qa_id":"QA:265e3805696199cb0d34d7cc","qa_group_id":"QAG:aa6a3e9794811e565c6678cc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Multivariate Cox analysis disclosed that 46 of 77 DRGs’ expression... |
QA:2ad11eee046b999338bd68ec | QAG:1bd54890285b725d67f5e11d | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Patients In the pilot study, 30 patients were enrolled and 43 samples were collected"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8ddb2cdd58cd0526b1593366","quotes":["Patients In the pilot study, 30 patients were enrolled, and 43 samples were ... | [
"CLM:8ddb2cdd58cd0526b1593366",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMID:33709991"
] | [
"SPAN:134bd96f56f85625cf85d44e",
"SPAN:e538032100a41de720d4f2ce"
] | [] | [] | {"qa_id":"QA:2ad11eee046b999338bd68ec","qa_group_id":"QAG:1bd54890285b725d67f5e11d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Patients In the pilot study, 30 patients were enrolled and 43 samp... |
QA:2e5a859d2dd034ca7d71e057 | QAG:6957c98fd94c2dc0ad2926b2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "We found high correlation between the observed and predicted drug responses in both colorectal cancer ( R 2 = 0.98) and bladder cancer organoids ( R 2 = 0.89) (Supplementary Fig. 17 ), which suggests that training the ML model with transcriptomes of proximal pathways h... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4beb76440091b02b5aad5613","quotes":["We found high correlation ... | [
"CLM:4beb76440091b02b5aad5613",
"CLM:b06dd56d5e900ad96df07e77",
"CLM:3534362f2a13bb5309c35d90",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMCID:PMC7599252",
"PMCID:PMC4830362",
"PMID:30261425"
] | [
"SPAN:eab69bbe992bbe1a67438848",
"SPAN:d2cce74a0e291981c9e35923",
"SPAN:440f50b100e1b5459f0aaf55"
] | [
"ASC2:fa4fe5760b4b63c1ec23fcc4",
"ASC2:533e917b1db0c459cfb25646"
] | [
"HYP:DCH:6d8eaa3fc39a01eb0797102b",
"HYP:DCH:7f92fd1f21c745843c40155b"
] | {"qa_id":"QA:2e5a859d2dd034ca7d71e057","qa_group_id":"QAG:6957c98fd94c2dc0ad2926b2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"We found high correlation between the observed and predicted drug ... |
QA:2ea14de0859aef90283cd22b | QAG:cf8cc48fa1a405a7c053aced | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "In our previous study, 21 we generated PDTOs from 30 samples from patients with stage IV CRC who received chemotherapy, which enabled us to correlate drug sensitivity in PDTOs with chemosensitivity in the clinic"? Return the original wording with paper, Claim, and Evid... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7d62ba8a0eeeb70812a293fb","quotes":["In our previous study, 21 we generated PDTOs from 30 samples from patients w... | [
"CLM:7d62ba8a0eeeb70812a293fb",
"CLM:b06dd56d5e900ad96df07e77"
] | [
"PMCID:PMC10072204"
] | [
"SPAN:3dc248808910a1656ab63c29"
] | [] | [] | {"qa_id":"QA:2ea14de0859aef90283cd22b","qa_group_id":"QAG:cf8cc48fa1a405a7c053aced","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"In our previous study, 21 we generated PDTOs from 30 samples from ... |
QA:3048b785e9de00019e6c7f54 | QAG:25c0df4c0c78728f65cc326e | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "It was observed that NIH3T3 cells promoted the kinetics of tumor organoid formation"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence S... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e49826e9ab803ef3c982098b","quotes":["It was observed that NIH3T... | [
"CLM:e49826e9ab803ef3c982098b",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:6c993178b3e2e0383c815678",
"CLM:de80640f7bcbdd26270d1cbb"
] | [
"PMID:34633791",
"PMCID:PMC5127645",
"PMCID:PMC10072204"
] | [
"SPAN:6e27e2e60d22b7d4b15d64e0",
"SPAN:dd4b077cd77906823659ea2d",
"SPAN:6e6fdbb34e5935f19e5a7a36",
"SPAN:44b65ae26b7b6d719b839cce",
"SPAN:7f5296582c2e59daed2d4772"
] | [
"ASC2:8664c74d9394f35741bb9174",
"ASC2:d530f59f45c88db6c33230f3"
] | [
"HYP:DCH:0154642ca6a3c97bc53f6f90",
"HYP:DCH:b40e5e28432694d8e3c78c92"
] | {"qa_id":"QA:3048b785e9de00019e6c7f54","qa_group_id":"QAG:25c0df4c0c78728f65cc326e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"It was observed that NIH3T3 cells promoted the kinetics of tumor o... |
QA:344e5ca3c1aa3ca7c0c0c1e9 | QAG:2815ff911ba2218b0b06d486 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "30 , 32 , 40 , 44 , 45 However, beyond the scope of this current study and the importance of given data here and our published and unpublished data on links between EMT and FBXW7, more recently, we have initiated a study using different approaches to explore molecular ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3534362f2a13bb5309c35d90","quotes":["30 , 32 , 40 , 44 , 45 However, beyond the scope of... | [
"CLM:3534362f2a13bb5309c35d90",
"CLM:910db38e3f606d63a75a2412",
"CLM:3a5d83a22549a75ae2253455",
"CLM:6c993178b3e2e0383c815678",
"CLM:ee5340e77d50a52ad1902b72"
] | [
"PMCID:PMC4830362",
"PMCID:PMC9863259",
"PMCID:PMC5127645"
] | [
"SPAN:d2cce74a0e291981c9e35923",
"SPAN:1b3bc93518394d8a1ac7643d",
"SPAN:6e6fdbb34e5935f19e5a7a36",
"SPAN:e626c91e06fc2cbaeb2f2891"
] | [
"ASC2:5b92f820953cbd9124b9d32d",
"ASC2:77cd8c6d6b9f76d4336bd75e"
] | [
"HYP:DCH:7fad72200d80b85d8b600415"
] | {"qa_id":"QA:344e5ca3c1aa3ca7c0c0c1e9","qa_group_id":"QAG:2815ff911ba2218b0b06d486","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"30 , 32 , 40 , 44 , 45 However, beyond the scope of this current s... |
QA:35a94cee2ae5e8d8351c765b | QAG:e684808aa11a7c4977fdcfff | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35691158? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35691158","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35691158"
] | [] | [] | [] | {"qa_id":"QA:35a94cee2ae5e8d8351c765b","qa_group_id":"QAG:e684808aa11a7c4977fdcfff","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35691158? E... |
QA:3c6cf8368a072f4bba996912 | QAG:f030e255129e239268d35c1f | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:37774672? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:37774672","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:37774672"
] | [] | [] | [] | {"qa_id":"QA:3c6cf8368a072f4bba996912","qa_group_id":"QAG:f030e255129e239268d35c1f","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:37774672? E... |
QA:41967eec988db0888fa80ab4 | QAG:1fc31cda1ea76dad8616e036 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC12978046? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC12978046","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC12978046"
] | [] | [] | [] | {"qa_id":"QA:41967eec988db0888fa80ab4","qa_group_id":"QAG:1fc31cda1ea76dad8616e036","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1297804... |
QA:4860bd6923d7f9583be88271 | QAG:aef2a90c7ba5240b23c99e4d | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Moreover, treatment of primary patient-derived colon cancer organoids was similarly efficient and led to increased apoptosis and decreased proliferation in both combined PKI/AZD as well as T/MK/AZD treatment"? Return the original wording with paper, Claim, and Evidence... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ee5340e77d50a52ad1902b72","quotes":["Moreover, treatment of primary patient-derived colo... | [
"CLM:ee5340e77d50a52ad1902b72",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:de80640f7bcbdd26270d1cbb",
"CLM_SUP:5a32018fa8cbc303bb9e406e",
"CLM_SUP:64fb7fd0f50505498fc5b44d"
] | [
"PMCID:PMC9863259",
"PMCID:PMC10072204",
"PMID:33709991"
] | [
"SPAN:e626c91e06fc2cbaeb2f2891",
"SPAN:44b65ae26b7b6d719b839cce",
"SPAN:7f5296582c2e59daed2d4772",
"SPAN_SUP:1792e8103bdf8986c0dc1d29",
"SPAN_SUP:97e8a8b85531c891e352f25c"
] | [
"ASC2:8e6b6761cba63bc6a3878b30",
"ASC2:365b2ea63f197dec49e05752"
] | [
"HYP:DCH:92a778ab39ce1e63ed6a2b80"
] | {"qa_id":"QA:4860bd6923d7f9583be88271","qa_group_id":"QAG:aef2a90c7ba5240b23c99e4d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Moreover, treatment of primary patient-derived colon cancer organo... |
QA:4a0a545ce79f9178d979f168 | QAG:8bd8293c937f6ef7db30e47e | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "For example, in a patient with right-sided colon cancer who underwent R0 resection and had adenocarcinoma, the probability of 12-month PFS for a patient with resistance indicated by the PDTO-based drug test was approximately 20%, and for patients with sensitivity indic... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8ddb7b65e496910d0ca6321d","quotes":["For example, in a patient with right-sided colon cancer who underwent R0 res... | [
"CLM:8ddb7b65e496910d0ca6321d",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10072204"
] | [
"SPAN:9f5fd5bc865b65f864be6549"
] | [] | [] | {"qa_id":"QA:4a0a545ce79f9178d979f168","qa_group_id":"QAG:8bd8293c937f6ef7db30e47e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"For example, in a patient with right-sided colon cancer who underw... |
QA:4bb9edeb4756fb89967f0975 | QAG:8a0785eb913f8128ef4baa4b | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6317967? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC6317967","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC6317967"
] | [] | [] | [] | {"qa_id":"QA:4bb9edeb4756fb89967f0975","qa_group_id":"QAG:8a0785eb913f8128ef4baa4b","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6317967... |
QA:4c7347c5c20b9fb0f04278d6 | QAG:0d2b9de75f939049db193b07 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived crc organoids p18t-kras received different combination therapies against the egfr-ras-erk pathway with addition of bcl2/bclxl inhibitor navitoclax and th"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenan... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:014740537b08b223a172c6b3","quotes":["Dose-response curves of patient-derived CRC org... | [
"CLM_SUP:014740537b08b223a172c6b3",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:ef45b3c1494f9cf78e2f842a"
] | [
"PMCID:PMC5127645",
"PMCID:PMC10705195"
] | [
"SPAN_SUP:e4e7feba61a8411657f2cd24",
"SPAN:5d622113352f3a93339b7092"
] | [
"ASC2:c8f262f197b93d196501fb7d"
] | [
"HYP:DCH:28a080c5f4c88fa5f216d498"
] | {"qa_id":"QA:4c7347c5c20b9fb0f04278d6","qa_group_id":"QAG:0d2b9de75f939049db193b07","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived crc organoids p18t-kras received different combina... |
QA:520d08d9baa965d34ad62493 | QAG:4f5437d6b77e18fabaa69fa1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "EXPERIMENTAL MODEL AND SUBJECT DETAILS CRC PDO and CRC CAF culture CRC PDOs were obtained from the Human Cancer Models Initiative (Sanger Institute, Cambridge, UK) 12 and expanded in 12-well plates (Helena Biosciences 92412T) in x3 25 mL droplets of Growth Factor decre... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d633a27f9272af337b82f7d8","quotes":["EXPERIMENTAL MODEL AND SUBJECT DETAILS\nCRC PDO and CRC CAF culture\nCRC PDO... | [
"CLM:d633a27f9272af337b82f7d8",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMID:38065081"
] | [
"SPAN:f0a63c28b51d2cf32a9d095e"
] | [] | [] | {"qa_id":"QA:520d08d9baa965d34ad62493","qa_group_id":"QAG:4f5437d6b77e18fabaa69fa1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"EXPERIMENTAL MODEL AND SUBJECT DETAILS CRC PDO and CRC CAF culture... |
QA:5222d9986adeddc4812ea61c | QAG:7f1b833577ba7a02edfc04c8 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC10530407? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC10530407","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC10530407"
] | [] | [] | [] | {"qa_id":"QA:5222d9986adeddc4812ea61c","qa_group_id":"QAG:7f1b833577ba7a02edfc04c8","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1053040... |
QA:5273406f64f882933fa1a2e3 | QAG:641a9e2b9e453780c854f38a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived kras mutant crc organoids p9t and p26t received the dual egfr/her2 inhibitor afatinib"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Cla... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:9b2fe8504bc44cbeb841ae5e","quotes":["Dose-response curves of patient-derived KRAS mutant CRC organoids P9T an... | [
"CLM_SUP:9b2fe8504bc44cbeb841ae5e",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC5127645"
] | [
"SPAN_SUP:fd7ec420dac6fc34f637c320"
] | [] | [] | {"qa_id":"QA:5273406f64f882933fa1a2e3","qa_group_id":"QAG:641a9e2b9e453780c854f38a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived kras mutant crc organoids p9t and p26t received th... |
QA:532ec8ccb85e3eaa5d700c55 | QAG:52fbf23f6c7d42ac3b96bc6e | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Intra-tumor heterogeneity (genotypic and functional diversity among cancer cells within the same tumor) represented one of the key challenges in cancer medicine"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requir... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d5cf7f03a5e8504f09acbe5f","quotes":["Intra-tumor heterogeneity (genotypic and functional diversity among cancer c... | [
"CLM:d5cf7f03a5e8504f09acbe5f",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMID:30261425"
] | [
"SPAN:58303611749f623592498f55"
] | [] | [] | {"qa_id":"QA:532ec8ccb85e3eaa5d700c55","qa_group_id":"QAG:52fbf23f6c7d42ac3b96bc6e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Intra-tumor heterogeneity (genotypic and functional diversity amon... |
QA:5343b7091454f246ae8c70d5 | QAG:abad87d827a25bac6284f94a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived tumor organoids predicted progression-free survival in patients with stage iv colorectal cancer after surgery"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:5a32018fa8cbc303bb9e406e","quotes":["CONCLUSIONS: Patient-derived tumor organoids ca... | [
"CLM_SUP:5a32018fa8cbc303bb9e406e",
"CLM:02ff8ab5ecc9755da71f1be3",
"CLM_SUP:64fb7fd0f50505498fc5b44d"
] | [
"PMCID:PMC10072204",
"PMID:33709991"
] | [
"SPAN_SUP:1792e8103bdf8986c0dc1d29",
"SPAN_SUP:97e8a8b85531c891e352f25c"
] | [
"ASC2:365b2ea63f197dec49e05752"
] | [
"HYP:DCH:e5cb8551cae0dec5757312b7"
] | {"qa_id":"QA:5343b7091454f246ae8c70d5","qa_group_id":"QAG:abad87d827a25bac6284f94a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived tumor organoids predicted progression-free surviva... |
QA:54eb38fa88f8f669732c93bc | QAG:37c6a1cd884e535d9e7d5449 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Rapamycin inhibits FBXW7 loss promoted epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b54d1f125363612ac32a3275","quotes":["Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and ... | [
"CLM:b54d1f125363612ac32a3275",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:dffb17a14ef65f0520795174"
] | [] | [] | {"qa_id":"QA:54eb38fa88f8f669732c93bc","qa_group_id":"QAG:37c6a1cd884e535d9e7d5449","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Rapamycin inhibits FBXW7 loss promoted epithelial-mesenchymal tran... |
QA:55c33ec472bd361be08f9f91 | QAG:b7a03fc83b08d4e56dfef990 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "The survival rate of patients with advanced CRC has been substantially improved due to the use of chemotherapeutics, the introduction of targeted therapies for specific tumor characteristics, and the combination of multidisciplinary methods"? Return the original wordin... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:715d70635718feefb56717f2","quotes":["The survival rate of patients with advanced CRC has been substantially impro... | [
"CLM:715d70635718feefb56717f2",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:be3e8559d6507bce9e67814b"
] | [] | [] | {"qa_id":"QA:55c33ec472bd361be08f9f91","qa_group_id":"QAG:b7a03fc83b08d4e56dfef990","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"The survival rate of patients with advanced CRC has been substanti... |
QA:568e426b24b0cc8abadd4f15 | QAG:1afb6aa2bc1783c633b28113 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Cu overload was associated with the progression and prognosis of colorectal cancer (CRC) 9"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:33c98ff8e87694040b6bb8ee","quotes":["Cu overload is associated with the progression and prognosis of colorectal c... | [
"CLM:33c98ff8e87694040b6bb8ee",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10367564"
] | [
"SPAN:9f3b3924ec8b0ef523e6a5b2"
] | [] | [] | {"qa_id":"QA:568e426b24b0cc8abadd4f15","qa_group_id":"QAG:1afb6aa2bc1783c633b28113","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Cu overload was associated with the progression and prognosis of c... |
QA:5c586fa7ef525f05f4f3d45c | QAG:ee9c7ac46b1001aac3881e6f | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "According to the literature, the Wnt/β-catenin signaling pathway was associated with chemoresistance in CRC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with pape... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1f76719e9372c7dee5e47742","quotes":["According to the literature, the Wnt/β-catenin signaling pathway is associat... | [
"CLM:1f76719e9372c7dee5e47742",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:b1ca56e5379a1c538863f693"
] | [] | [] | {"qa_id":"QA:5c586fa7ef525f05f4f3d45c","qa_group_id":"QAG:ee9c7ac46b1001aac3881e6f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"According to the literature, the Wnt/β-catenin signaling pathway w... |
QA:5d83fbcaf9347bf7e3eebb11 | QAG:bb757745eedc8e6503a3af37 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "RC tumoroids retained molecular features of the tumors from which they were derived, and their ex vivo responses to clinically relevant chemotherapy and radiation treatment correlated with the clinical responses noted in individual patients' tumors"? Return the origina... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:79dbd1795c2e01ceceba8990","quotes":["RC tumoroids retained molecular features of the tumors from which they were ... | [
"CLM:79dbd1795c2e01ceceba8990",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMCID:PMC7385919"
] | [
"SPAN:09b219148c84c303e06fe413"
] | [] | [] | {"qa_id":"QA:5d83fbcaf9347bf7e3eebb11","qa_group_id":"QAG:bb757745eedc8e6503a3af37","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"RC tumoroids retained molecular features of the tumors from which ... |
QA:5deedaf9ca13e8a178021c2f | QAG:32cdfa94733ea17f41fbd332 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Previous studies have reported that the Wnt/β-catenin signaling pathway was associated with chemoresistance in CRC"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage wi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fedbd665376dc8cccd3280a9","quotes":["Previous studies have reported that the Wnt/β-catenin signaling pathway is a... | [
"CLM:fedbd665376dc8cccd3280a9",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:dd23342d025e8242453efc1a"
] | [] | [] | {"qa_id":"QA:5deedaf9ca13e8a178021c2f","qa_group_id":"QAG:32cdfa94733ea17f41fbd332","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Previous studies have reported that the Wnt/β-catenin signaling pa... |
QA:5e9adf79def63a544aedc4d3 | QAG:d88a171915f9836638293711 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "With further research, our present findings can contribute to increased favorable prognoses and OS for CRC patients by providing personalized chemotherapy through high-precision prediction models"? Return the original wording with paper, Claim, and Evidence Span refere... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9a5cbd4d51a7d189b1928726","quotes":["With further research, our present findings can contribute to increased favo... | [
"CLM:9a5cbd4d51a7d189b1928726",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:f54980788bbae40304e871c6"
] | [] | [] | {"qa_id":"QA:5e9adf79def63a544aedc4d3","qa_group_id":"QAG:d88a171915f9836638293711","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"With further research, our present findings can contribute to incr... |
QA:616a25304b1a1e279f2bdfd5 | QAG:80966d0391ec38de5b2fd8db | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35907519? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35907519","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35907519"
] | [] | [] | [] | {"qa_id":"QA:616a25304b1a1e279f2bdfd5","qa_group_id":"QAG:80966d0391ec38de5b2fd8db","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35907519? E... |
QA:62d272ba48a8796c22cbf846 | QAG:1d47be39d4a6bbb7b3d5c73a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived crc organoids p18t-kras g12d received the dual egfr/her2 inhibitor afatinib"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Ev... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:ce2b739677580355536bf0b5","quotes":["( A ) Dose-response curves of patient-derived CRC organoids P18T-KRAS G1... | [
"CLM_SUP:ce2b739677580355536bf0b5",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC5127645"
] | [
"SPAN_SUP:2c311b8b7fa0f344b8b153b7"
] | [] | [] | {"qa_id":"QA:62d272ba48a8796c22cbf846","qa_group_id":"QAG:1d47be39d4a6bbb7b3d5c73a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived crc organoids p18t-kras g12d received the dual egf... |
QA:6c7f5bfae9802c1d1c9b21b8 | QAG:f4642130f141f0a334eca129 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "It was worth noting that only stage II–IV CRCpts were enrolled in the current study because patients with stage I disease underwent surgical resection but did not receive 5-Fu chemotherapy"? Return the original wording with paper, Claim, and Evidence Span references.
... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e47544b765c3cdd2d7e69c68","quotes":["It was worth noting that only stage II–IV CRCpts were enrolled in the curren... | [
"CLM:e47544b765c3cdd2d7e69c68",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC9004628"
] | [
"SPAN:6b187f19372a9267466c1543",
"SPAN:a9e5dc154fc4228ee41ef1b1"
] | [] | [] | {"qa_id":"QA:6c7f5bfae9802c1d1c9b21b8","qa_group_id":"QAG:f4642130f141f0a334eca129","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"It was worth noting that only stage II–IV CRCpts were enrolled in ... |
QA:7af58104e6a78f3aa6c103da | QAG:dc9a6981c5818027359e8f57 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Cetuximab increased the Cytotoxic Activity of Immune Cells during Treatment of Colorectal Cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, a... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3271ad4dde69864aa497bbfe","quotes":["30. Wang L, Wei Y, Fang W, Lu C, Chen J, Cui G, et al. Cetuximab Enhanced th... | [
"CLM:3271ad4dde69864aa497bbfe",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC6457557"
] | [
"SPAN:88c16047ca3907d9600d10e7"
] | [] | [] | {"qa_id":"QA:7af58104e6a78f3aa6c103da","qa_group_id":"QAG:dc9a6981c5818027359e8f57","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Cetuximab increased the Cytotoxic Activity of Immune Cells during ... |
QA:7ba1f01b9984ea18064a9fd6 | QAG:7f54ae012f1b31b6f6fd2af2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "If this research progresses, it can ultimately contribute to increased favorable prognoses and OS for colorectal cancer patients by providing personalized chemotherapy through high-precision prediction models"? Return the original wording with paper, Claim, and Evidenc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d085cc1f78d80c5f4ee33ed3","quotes":["If this research progresses, it can ultimately contribute to increased favor... | [
"CLM:d085cc1f78d80c5f4ee33ed3",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:8c64c6fbe95662045aed7e97"
] | [] | [] | {"qa_id":"QA:7ba1f01b9984ea18064a9fd6","qa_group_id":"QAG:7f54ae012f1b31b6f6fd2af2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"If this research progresses, it can ultimately contribute to incre... |
QA:7c2ed1cdfede7f92a995bae4 | QAG:a2b87d0733961fb990fe13e3 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6774804? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC6774804","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC6774804"
] | [] | [] | [] | {"qa_id":"QA:7c2ed1cdfede7f92a995bae4","qa_group_id":"QAG:a2b87d0733961fb990fe13e3","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6774804... |
QA:7f60124f9f33bfcb22808011 | QAG:527945cc1bc53f6d255d825a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "However, this is not the case for all CRC patients, since a subset of tumors do not respond as predicted presumably because of the presence of additional genetic alterations confounding genetic interactions"? Return the original wording with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0f5b405cc756bd984e1a5182","quotes":["However, this is not the case for all CRC patients, since a subset of tumors... | [
"CLM:0f5b405cc756bd984e1a5182",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC4335404"
] | [
"SPAN:7b4a1764760fc3591e085f81"
] | [] | [] | {"qa_id":"QA:7f60124f9f33bfcb22808011","qa_group_id":"QAG:527945cc1bc53f6d255d825a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"However, this is not the case for all CRC patients, since a subset... |
QA:8467e4ffcd9b471a21917b9e | QAG:1acdbcdf5a9b96b243731b45 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "As heterogeneity of cancer cells constitutes an important parameter in the development of therapy resistance, an accurate assessment of intra-tumor heterogeneity was essential for the prediction of drug resistance and development of effective treatment"? Return the ori... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e824127c3842ffd02a279fc9","quotes":["As heterogeneity of cancer cells constitutes an important parameter in the d... | [
"CLM:e824127c3842ffd02a279fc9",
"CLM:059e67f3b234cf4911e5e52b"
] | [
"PMID:30261425"
] | [
"SPAN:405a02f2ab4051c46f9a3e7c"
] | [] | [] | {"qa_id":"QA:8467e4ffcd9b471a21917b9e","qa_group_id":"QAG:1acdbcdf5a9b96b243731b45","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"As heterogeneity of cancer cells constitutes an important paramete... |
QA:86fbd3d6a14e4a3a030a2133 | QAG:a9f5bad78f92008701f35243 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "A Wnt promoted Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits Emt in Colorectal Cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8ef051b60489ae5de7863b3b","quotes":["A Wnt-Induced Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits Em... | [
"CLM:8ef051b60489ae5de7863b3b",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:dd5cfe429f811d9133a3cd23"
] | [] | [] | {"qa_id":"QA:86fbd3d6a14e4a3a030a2133","qa_group_id":"QAG:a9f5bad78f92008701f35243","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"A Wnt promoted Phenotypic Switch in Cancer-Associated Fibroblasts ... |
QA:87a7eafd6a6e1d9e2a740e77 | QAG:bc545f360848c10ae511893e | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "A total of 1,281 CRC patients from three Gene Expression Omnibus (GEO) databases were enrolled (accession # GSE39582 , # GSE196576 , and # GSE28702 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ret... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ac046406177eba3bbad70d5b","quotes":["A total of 1,281 CRC patients from three Gene Expression Omnibus (GEO) datab... | [
"CLM:ac046406177eba3bbad70d5b",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10367564"
] | [
"SPAN:866fd49b926e193d8435da1f"
] | [] | [] | {"qa_id":"QA:87a7eafd6a6e1d9e2a740e77","qa_group_id":"QAG:bc545f360848c10ae511893e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"A total of 1,281 CRC patients from three Gene Expression Omnibus (... |
QA:897f969a9d00771ffbaf8fd2 | QAG:36036315dba904435e452c77 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "RC tumoroids retained molecular features of the tumors from which they were derived, and their ex vivo responses to clinically relevant chemotherapy and radiation treatment was correlated with the clinical responses noted in individual patients' tumors"? Return the ori... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0a58aec46a1065fe9c48847b","quotes":["RC tumoroids retained molecular features of the tumors from which they were ... | [
"CLM:0a58aec46a1065fe9c48847b",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMCID:PMC7385919"
] | [
"SPAN:09b219148c84c303e06fe413"
] | [] | [] | {"qa_id":"QA:897f969a9d00771ffbaf8fd2","qa_group_id":"QAG:36036315dba904435e452c77","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"RC tumoroids retained molecular features of the tumors from which ... |
QA:90edb976644102c529e3d656 | QAG:b01f4c40cbbbce165a8199c3 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6527507? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC6527507","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC6527507"
] | [] | [] | [] | {"qa_id":"QA:90edb976644102c529e3d656","qa_group_id":"QAG:b01f4c40cbbbce165a8199c3","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC6527507... |
QA:99688b5464c1f5ffb12dce35 | QAG:e687cf0f274ea148c18643ab | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "the IC 50 of fbxw7 mutant mini-guts was higher than controls (5.7 versus 2.6 μmol/l 5-FU, respectively) ( Figure 3c )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f3224ce5a2b67f109091305f","quotes":["Consistent with CRC cell lines, we further confirmed that Fbxw7 deficiency c... | [
"CLM:f3224ce5a2b67f109091305f",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:414f5899289b31aa0fae40ca"
] | [] | [] | {"qa_id":"QA:99688b5464c1f5ffb12dce35","qa_group_id":"QAG:e687cf0f274ea148c18643ab","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"the IC 50 of fbxw7 mutant mini-guts was higher than controls (5.7 ... |
QA:a46962989002cc58704463d3 | QAG:1136ec8a8d73c3ae09c2a89b | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "( A ) Schematic representation of the CRISPR/Cas9 promoted homologous recombination strategy to introduce the KRAS G12D mutation in the KRAS WT patient-derived CRC organoid P18T"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:964599b1ed749bd860036142","quotes":["10.7554/eLife.18489.010 Figure 3. CRISPR genome edi... | [
"CLM:964599b1ed749bd860036142",
"CLM:0a58aec46a1065fe9c48847b",
"CLM_SUP:64fb7fd0f50505498fc5b44d"
] | [
"PMCID:PMC5127645",
"PMID:33709991"
] | [
"SPAN:7ea72f4e959671bb7008971e",
"SPAN_SUP:97e8a8b85531c891e352f25c"
] | [
"ASC2:7806e5e8f505dd152e7a2530"
] | [
"HYP:DCH:3a602efb2c5e2f3031c9f390"
] | {"qa_id":"QA:a46962989002cc58704463d3","qa_group_id":"QAG:1136ec8a8d73c3ae09c2a89b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"( A ) Schematic representation of the CRISPR/Cas9 promoted homolog... |
QA:a509e094529fcf882e49bdbb | QAG:8b5a9266eb5f867854889424 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Analysis of 172 CRC surgical specimens revealed that high STAG3 expression was associated with poor prognosis"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:112d6871a86efb0739067458","quotes":["Analysis of 172 CRC surgical specimens revealed that high STAG3 expression w... | [
"CLM:112d6871a86efb0739067458",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMID:33039558"
] | [
"SPAN:f8130b44cc110dda36368d41"
] | [] | [] | {"qa_id":"QA:a509e094529fcf882e49bdbb","qa_group_id":"QAG:8b5a9266eb5f867854889424","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Analysis of 172 CRC surgical specimens revealed that high STAG3 ex... |
QA:a5d79d3440d2df186b8ca6d1 | QAG:d86e47653eb00b14f2c0f927 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "As a negative control, we compared the differences in overall survival of 298 colorectal cancer patients with no prior treatment who were predicted to be sensitive or resistant to 5FU treatment (Fig. 2d )"? Return the original wording with paper, Claim, and Evidence Sp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9b2ae1447430367097d89814","quotes":["As a negative control, we compared the differences in overall survival of 29... | [
"CLM:9b2ae1447430367097d89814",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC7599252"
] | [
"SPAN:40ae117c894dced7a81d8602"
] | [] | [] | {"qa_id":"QA:a5d79d3440d2df186b8ca6d1","qa_group_id":"QAG:d86e47653eb00b14f2c0f927","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"As a negative control, we compared the differences in overall surv... |
QA:a5e71e2ab2669bebba1d3783 | QAG:3686cd22257ba3343e02b6a5 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "We found that the expression levels of the components of the “activation of BH3-only proteins” pathway was associated with the responses of colorectal cancer organoids to 5FU treatment"? Return the original wording with paper, Claim, and Evidence Span references.
Inte... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9784298cad461ea96f6cabec","quotes":["We found that the expression levels of the components of the “activation of ... | [
"CLM:9784298cad461ea96f6cabec",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC7599252"
] | [
"SPAN:3fb3f56265f4eec55b0cfeb5"
] | [] | [] | {"qa_id":"QA:a5e71e2ab2669bebba1d3783","qa_group_id":"QAG:3686cd22257ba3343e02b6a5","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"We found that the expression levels of the components of the “acti... |
QA:a6228dbc3fd993bac9d62d82 | QAG:0faa7e53af8e7914aeb4df5a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Finally, we address the exciting recent results that showed that tumor organoid technology is highly predictive for drug response in metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d6cf25e9df24e15ceeac556a","quotes":["Finally, we address the ex... | [
"CLM:d6cf25e9df24e15ceeac556a",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:6627364fd1e47da0d8f06e70",
"CLM:a6b95e4bd8a8acf73bc9ba67",
"CLM:4beb76440091b02b5aad5613",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMID:30261425",
"PMCID:PMC5127645",
"PMCID:PMC6457557",
"PMCID:PMC7599252"
] | [
"SPAN:d4a3832497d3396828b39d40",
"SPAN:69d5b0c787468fc7945efef2",
"SPAN:f6dcfd8170d15a611d255fef",
"SPAN:440f50b100e1b5459f0aaf55",
"SPAN:eab69bbe992bbe1a67438848"
] | [
"ASC2:53a1cc586b5a13cacde98b8c",
"ASC2:e87b1d6b884d3b661af2a2ed",
"ASC2:533e917b1db0c459cfb25646",
"ASC2:ec5f54b918dee48afaff30cf"
] | [
"HYP:DCH:3d1ae445f1b242a5bc980add",
"HYP:DCH:cee4bf86bdb6e94338ed68d3"
] | {"qa_id":"QA:a6228dbc3fd993bac9d62d82","qa_group_id":"QAG:0faa7e53af8e7914aeb4df5a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Finally, we address the exciting recent results that showed that t... |
QA:a65af2a7d911907898b012f4 | QAG:f84418ff55161fcb96ad6c40 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "21 different rectal cancer (RC) organoids were separately treated with 5-FU and FOLFOX (a chemotherapy regimen of 5-FU, leucovorin, and oxaliplatin), and 19 RC organoids were received radiation treatment"? Return the original wording with paper, Claim, and Evidence Spa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f54069ba209b0b546772576d","quotes":["21 different rectal cancer (RC) organoids were separately treated with 5-FU ... | [
"CLM:f54069ba209b0b546772576d",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:d373e0eccc6d6a6a606a3406"
] | [] | [] | {"qa_id":"QA:a65af2a7d911907898b012f4","qa_group_id":"QAG:f84418ff55161fcb96ad6c40","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"21 different rectal cancer (RC) organoids were separately treated ... |
QA:a6d187c975fd967cfc89cc84 | QAG:7331f8e57c0d20a19d683f64 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Figure 8 CRC PDO drug sensitivity predicted response to treatment with oxaliplatin in the M-ORG media condition. ( A ) CRC-166T organoids were administered increasing doses of oxaliplatin (0.024~100 μM) for 5 days in three different culture media (TCCM/ORG/M-ORG)"? Ret... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ef45b3c1494f9cf78e2f842a","quotes":["Figure 8 CRC PDO drug sensitivity predicts response... | [
"CLM:ef45b3c1494f9cf78e2f842a",
"CLM:0a58aec46a1065fe9c48847b",
"CLM_SUP:36f0a2fc82a23eecf6424f55"
] | [
"PMCID:PMC10705195",
"PMCID:PMC10072204"
] | [
"SPAN:5d622113352f3a93339b7092",
"SPAN_SUP:f653115bb6cb7c3ee616e90c"
] | [
"ASC2:25fba721279a7de7d79ffab8"
] | [
"HYP:DCH:5cfe45e5ade56bb69673da29"
] | {"qa_id":"QA:a6d187c975fd967cfc89cc84","qa_group_id":"QAG:7331f8e57c0d20a19d683f64","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Figure 8 CRC PDO drug sensitivity predicted response to treatment ... |
QA:a806e8f7ab2f27a659f3cc7e | QAG:d9594522a4f7141d983ca89f | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Particularly, in BRAF-mutant CRC cells, STAG3 silencing inhibited the expression of snail family transcriptional repressor 1 and phosphorylation of extracellular signal-regulated kinase via upregulation of dual-specificity phosphatase 6. Our findings suggest that STAG3... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9a260dc82c1bc0c36ca58fa1","quotes":["Particularly, in BRAF-mutant CRC cells, STAG3 silencing suppressed the expre... | [
"CLM:9a260dc82c1bc0c36ca58fa1",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMID:33039558"
] | [
"SPAN:8a437dd5e910ba5f03b9da0d"
] | [] | [] | {"qa_id":"QA:a806e8f7ab2f27a659f3cc7e","qa_group_id":"QAG:d9594522a4f7141d983ca89f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Particularly, in BRAF-mutant CRC cells, STAG3 silencing inhibited ... |
QA:aa63e029839db28574b2eff4 | QAG:227ef966076c901b35dd9222 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "the predictive accuracy of patient-derived tumor organoid culture models for responses to chemotherapy regimens in stage iv colorectal cancer remains unknown"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requireme... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:64fb7fd0f50505498fc5b44d","quotes":["However, the predictive accuracy of patient-derived tumor organoid cultu... | [
"CLM_SUP:64fb7fd0f50505498fc5b44d",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMID:33709991"
] | [
"SPAN_SUP:97e8a8b85531c891e352f25c"
] | [] | [] | {"qa_id":"QA:aa63e029839db28574b2eff4","qa_group_id":"QAG:227ef966076c901b35dd9222","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"the predictive accuracy of patient-derived tumor organoid culture ... |
QA:bb0cb7cadc4d598c11588a75 | QAG:7d4f5ff551992b3323ab05df | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Recently, several groups have described patient-derived colorectal cancer organoids as a discovery platform for therapeutics and for validating the predicted impact of molecular features on therapy responses"? Return the original wording with paper, Claim, and Evidence... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a6b95e4bd8a8acf73bc9ba67","quotes":["Recently, several groups have described patient-der... | [
"CLM:a6b95e4bd8a8acf73bc9ba67",
"CLM:5ef8a344ca03ab96e5854565",
"CLM:d6cf25e9df24e15ceeac556a"
] | [
"PMCID:PMC6457557",
"PMID:30261425"
] | [
"SPAN:f6dcfd8170d15a611d255fef",
"SPAN:d4a3832497d3396828b39d40"
] | [
"ASC2:ec5f54b918dee48afaff30cf"
] | [
"HYP:DCH:2e265eb46b62295feb734a3f"
] | {"qa_id":"QA:bb0cb7cadc4d598c11588a75","qa_group_id":"QAG:7d4f5ff551992b3323ab05df","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Recently, several groups have described patient-derived colorectal... |
QA:bb4fb94d991661c55e4d7169 | QAG:db2991974f8d47d55768d3af | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "2018 ) surgically implanted CRC organoids into the cecum of mice, which led to tumor metastasis to the liver and lung with 100% efficiency"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:059e67f3b234cf4911e5e52b","quotes":["Fumagalli et al. ( Fumagalli et al., 2018 ) surgically implanted CRC organoi... | [
"CLM:059e67f3b234cf4911e5e52b",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:15f91bd2640e6c9aeb8aebb3"
] | [] | [] | {"qa_id":"QA:bb4fb94d991661c55e4d7169","qa_group_id":"QAG:db2991974f8d47d55768d3af","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"2018 ) surgically implanted CRC organoids into the cecum of mice, ... |
QA:bd6b058b5af55f9c021ec0de | QAG:b791d19858c08842e1dc52c4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "In all of the four enrolled GEO cohorts, the univariate Cox regression model indicated that the DRS was associated with prognosis of CRC patients in terms of OS or DSS with the P values of 8e–04 ( GSE40967 ), 0.0016 ( GSE17538 ), 0.018 ( GSE87211 ), and 0.0044 ( GSE388... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3446d7b53c282b7a429cb904","quotes":["In all of the four enrolled GEO cohorts, the univariate Cox regression model... | [
"CLM:3446d7b53c282b7a429cb904",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC9004628"
] | [
"SPAN:37a6f610daf31e14e98f77da"
] | [] | [] | {"qa_id":"QA:bd6b058b5af55f9c021ec0de","qa_group_id":"QAG:b791d19858c08842e1dc52c4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"In all of the four enrolled GEO cohorts, the univariate Cox regres... |
QA:c0b00a391f309d8a0dc0add0 | QAG:7ffae6e4260128d12b4f17e9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Furthermore, we included organoid use to understand intra-tumor heterogeneity, both in terms of mutational diversification and of diversification in drug sensitivity"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:5ef8a344ca03ab96e5854565","quotes":["Furthermore, we discuss organoid use to understand ... | [
"CLM:5ef8a344ca03ab96e5854565",
"CLM:02ff8ab5ecc9755da71f1be3",
"CLM:3a5d83a22549a75ae2253455"
] | [
"PMID:30261425",
"PMCID:PMC9863259"
] | [
"SPAN:440f50b100e1b5459f0aaf55",
"SPAN:1b3bc93518394d8a1ac7643d"
] | [
"ASC2:35c3818f1e17f0aa70041c9c"
] | [
"HYP:DCH:5e324cfe296e1371e62e36e0"
] | {"qa_id":"QA:c0b00a391f309d8a0dc0add0","qa_group_id":"QAG:7ffae6e4260128d12b4f17e9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Furthermore, we included organoid use to understand intra-tumor he... |
QA:c2c1d91431a885742f6afe1b | QAG:b2499e81e5afb7127af4ffce | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "All patients were included before they received their last SOC treatment line (irinotecan-based therapy or anti-EGFR mABs), while all had progressed on one or two prior lines of SOC treatment (containing 5-fluoruracil, with or without oxaliplatin and/or irinotecan) acc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:afa6a51ee4aba6bffedf9faf","quotes":["All patients were included before they received their last SOC treatment lin... | [
"CLM:afa6a51ee4aba6bffedf9faf",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMCID:PMC8086019"
] | [
"SPAN:f7def0ab2bf10ef60258b302"
] | [] | [] | {"qa_id":"QA:c2c1d91431a885742f6afe1b","qa_group_id":"QAG:b2499e81e5afb7127af4ffce","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"All patients were included before they received their last SOC tre... |
QA:c425ab91b800506d5af4aaac | QAG:66e1b5bc6a9e39b77721ea49 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35696669? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35696669","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35696669"
] | [] | [] | [] | {"qa_id":"QA:c425ab91b800506d5af4aaac","qa_group_id":"QAG:66e1b5bc6a9e39b77721ea49","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35696669? E... |
QA:c597ab2ad3f32d693de2fbfe | QAG:467b3e43b04265000cf7a76b | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "In this study, we found that the PDTO drug test was a prognostic factor for PFS in patients with stage IV CRC ( p < 0.001)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4a2f95453bf5e80e29ec6ea7","quotes":["In this study, we found that the PDTO drug test was an independent prognosti... | [
"CLM:4a2f95453bf5e80e29ec6ea7",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10072204"
] | [
"SPAN:6c44999a3b3fcba06e861359"
] | [] | [] | {"qa_id":"QA:c597ab2ad3f32d693de2fbfe","qa_group_id":"QAG:467b3e43b04265000cf7a76b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"In this study, we found that the PDTO drug test was a prognostic f... |
QA:c6edef6d0a7aff1b636f6b09 | QAG:1b5b2c12288cab0e54068af6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Robust inhibition of the EGFR-RAS-ERK pathway sensitizes for navitoclax promoted cell death. ( A ) Dose-response curves of patient-derived CRC organoids P18T-KRAS G12D treated with the dual EGFR/HER2 inhibitor afatinib, MEK inhibitor selumetinib, BCL2/BCLXL inhibitor n... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6c993178b3e2e0383c815678","quotes":["10.7554/eLife.18489.034 Figure 9. Robust inhibition... | [
"CLM:6c993178b3e2e0383c815678",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:ee5340e77d50a52ad1902b72"
] | [
"PMCID:PMC5127645",
"PMCID:PMC9863259"
] | [
"SPAN:6e6fdbb34e5935f19e5a7a36",
"SPAN:e626c91e06fc2cbaeb2f2891"
] | [
"ASC2:77cd8c6d6b9f76d4336bd75e"
] | [
"HYP:DCH:b2016c57488d0d60afd61f37"
] | {"qa_id":"QA:c6edef6d0a7aff1b636f6b09","qa_group_id":"QAG:1b5b2c12288cab0e54068af6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Robust inhibition of the EGFR-RAS-ERK pathway sensitizes for navit... |
QA:c758e8af96183b3d8d0752ac | QAG:ed39d14861739157fd35d4ab | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Dysregulation of KRAS signaling in pancreatic cancer was not associated with KRAS mutations and outcome"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b06dd56d5e900ad96df07e77","quotes":["37. Lemstrova R, Brynychova V, Hughes DJ, Hlavac V, Dvorak P, Doherty JE, et... | [
"CLM:b06dd56d5e900ad96df07e77",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMCID:PMC6457557"
] | [
"SPAN:5dc5a5f8bd53ac42a3355e0b"
] | [] | [] | {"qa_id":"QA:c758e8af96183b3d8d0752ac","qa_group_id":"QAG:ed39d14861739157fd35d4ab","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Dysregulation of KRAS signaling in pancreatic cancer was not assoc... |
QA:c7d0b8e5bd43a85c76d4f377 | QAG:e5ad1db0cc39914abcf1f19a | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Using our network-based approach, we found that the “Gastrin-CREB signaling pathway via PKC and MAPK” pathway was associated with the response to cetuximab treatment in colorectal cancer organoids (Supplementary Fig. 11 )"? Return the original wording with paper, Claim... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f08a0998caa2a00870e5062c","quotes":["Using our network-based approach, we found that the “Gastrin-CREB signaling ... | [
"CLM:f08a0998caa2a00870e5062c",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC7599252"
] | [
"SPAN:e8c72d2cfb3b534acc50c2a4"
] | [] | [] | {"qa_id":"QA:c7d0b8e5bd43a85c76d4f377","qa_group_id":"QAG:e5ad1db0cc39914abcf1f19a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Using our network-based approach, we found that the “Gastrin-CREB ... |
QA:c94617f067a1893e16acb1c7 | QAG:14f32e2cba7cd5c26d0a66d1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "For obstructive left-sided colon cancer that was not suitable for primary anastomosis after assessment, patients received diversion colostomy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:927559fa9f39ecc9c86455e3","quotes":["For obstructive left-sided colon cancer that was not suitable for primary an... | [
"CLM:927559fa9f39ecc9c86455e3",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10072204"
] | [
"SPAN:f14fc4c68ac42bffbfc115a9"
] | [] | [] | {"qa_id":"QA:c94617f067a1893e16acb1c7","qa_group_id":"QAG:14f32e2cba7cd5c26d0a66d1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"For obstructive left-sided colon cancer that was not suitable for ... |
QA:cd6217625365a00cdd9891f0 | QAG:b92175a7fb0ac9336a63e965 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Patients with stage IV CRC received multidisciplinary team (MDT) consultations after hospitalization"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Clai... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9d82747f3918876e443279de","quotes":["Patients with stage IV CRC received multidisciplinary team (MDT) consultatio... | [
"CLM:9d82747f3918876e443279de",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10072204"
] | [
"SPAN:b66e27ef78ba08420fea7729"
] | [] | [] | {"qa_id":"QA:cd6217625365a00cdd9891f0","qa_group_id":"QAG:b92175a7fb0ac9336a63e965","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Patients with stage IV CRC received multidisciplinary team (MDT) c... |
QA:cdd3e2166c425a7e95f88d4f | QAG:76a8d646cfa93595371ad5f8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "The results showed that Fbxw7α overexpression decreased the 5-FU IC50 and inhibited FBXW7 mutation in mediating 5-FU drug-resistance of CRC cell lines"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: re... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4d6436d7508552c5a9d4afda","quotes":["The results showed that Fbxw7α overexpression significantly decreased the 5-... | [
"CLM:4d6436d7508552c5a9d4afda",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC4830362"
] | [
"SPAN:4091256595eb106258166195"
] | [] | [] | {"qa_id":"QA:cdd3e2166c425a7e95f88d4f","qa_group_id":"QAG:76a8d646cfa93595371ad5f8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"The results showed that Fbxw7α overexpression decreased the 5-FU I... |
QA:d20453aa0a0f27b5eedb978f | QAG:c422ccc1366f6f9f7a86c073 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "2020 ) generated paired organoids derived from primary tumors and matched liver metastases in the same CRC patients and showed that inducible knockdown of SOX2 decreased invasion, proliferation, and liver metastasis outgrowth"? Return the original wording with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e088859b00317ec93d7baf4e","quotes":["He et al. ( Li et al., 2020 ) generated paired organoids derived from primar... | [
"CLM:e088859b00317ec93d7baf4e",
"CLM:1cac52e2cbd154d19265a10b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:7e62e25027222281effc7476"
] | [] | [] | {"qa_id":"QA:d20453aa0a0f27b5eedb978f","qa_group_id":"QAG:c422ccc1366f6f9f7a86c073","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"2020 ) generated paired organoids derived from primary tumors and ... |
QA:d62f3f8398721499aee3a799 | QAG:2b9d04c0ca165e32fce4e86c | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC5030729? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC5030729","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC5030729"
] | [] | [] | [] | {"qa_id":"QA:d62f3f8398721499aee3a799","qa_group_id":"QAG:2b9d04c0ca165e32fce4e86c","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC5030729... |
QA:e08e63d11110a31ac8ad1d0f | QAG:fb8470d270bc388e4e5ef325 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "All patients were included before they received their last SOC treatment line (irinotecan-based therapy or anti-EGFR mABs), while all had progressed on one or two prior lines of SOC treatment (containing 5-fluoruracil, with or without oxaliplatin and/or irinotecan) acc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:caa55e7b31cd037fd4bf9caf","quotes":["All patients were included before they received their last SOC treatment lin... | [
"CLM:caa55e7b31cd037fd4bf9caf",
"CLM:5ef8a344ca03ab96e5854565"
] | [
"PMCID:PMC8086019"
] | [
"SPAN:f7def0ab2bf10ef60258b302"
] | [] | [] | {"qa_id":"QA:e08e63d11110a31ac8ad1d0f","qa_group_id":"QAG:fb8470d270bc388e4e5ef325","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"All patients were included before they received their last SOC tre... |
QA:e4454822d8bf0e247175a415 | QAG:205ddde450ba01a1b584f89f | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "patient-derived organoids predicted response to chemotherapy in metastatic colorectal cancer patients"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Cla... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM_SUP:bbdaacd1e75f59f252baeffb","quotes":["Patient-derived organoids can predict response to chemotherapy in metast... | [
"CLM_SUP:bbdaacd1e75f59f252baeffb",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMCID:PMC10072204"
] | [
"SPAN_SUP:36729bc994e2055c08b7182e"
] | [] | [] | {"qa_id":"QA:e4454822d8bf0e247175a415","qa_group_id":"QAG:205ddde450ba01a1b584f89f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"patient-derived organoids predicted response to chemotherapy in me... |
QA:e456ca63a673ef1a054610fc | QAG:ba05a904ed91de4ab0f2d3c3 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Treatment promoted profound organoid disintegration after 48 h as evident in phase contrast microscopy images from two patients ( Figure 5 A, colon cancer from primary site; Figure 5 B, colon cancer liver metastasis)"? Return the original wording with paper, Claim, and... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3a5d83a22549a75ae2253455","quotes":["Treatment induced profound organoid disintegration ... | [
"CLM:3a5d83a22549a75ae2253455",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:3534362f2a13bb5309c35d90"
] | [
"PMCID:PMC9863259",
"PMCID:PMC4830362"
] | [
"SPAN:1b3bc93518394d8a1ac7643d",
"SPAN:d2cce74a0e291981c9e35923"
] | [
"ASC2:5b92f820953cbd9124b9d32d"
] | [
"HYP:DCH:1056fefd139b574f44eeab23"
] | {"qa_id":"QA:e456ca63a673ef1a054610fc","qa_group_id":"QAG:ba05a904ed91de4ab0f2d3c3","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Treatment promoted profound organoid disintegration after 48 h as ... |
QA:e497926cb0759757bf77bcba | QAG:1ec2ad483db2d974c92ad7c1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "As heterogeneity of cancer cells constituted an important parameter in the development of therapy resistance, an accurate assessment of intra-tumor heterogeneity is essential for the prediction of drug resistance and development of effective treatment"? Return the orig... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:1cac52e2cbd154d19265a10b","quotes":["As heterogeneity of cancer cells constitutes an important parameter in the d... | [
"CLM:1cac52e2cbd154d19265a10b",
"CLM:059e67f3b234cf4911e5e52b"
] | [
"PMID:30261425"
] | [
"SPAN:405a02f2ab4051c46f9a3e7c"
] | [] | [] | {"qa_id":"QA:e497926cb0759757bf77bcba","qa_group_id":"QAG:1ec2ad483db2d974c92ad7c1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"As heterogeneity of cancer cells constituted an important paramete... |
QA:e530bf8f12052fda96f89899 | QAG:3ddf1942a5ba6214bac862fc | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Importantly, engrafted tumors exhibited the heterogenous sensitivity to chemotherapy observed clinically"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:910db38e3f606d63a75a2412","quotes":["Importantly, engrafted tumors displayed the heterogenous sensitivity to chem... | [
"CLM:910db38e3f606d63a75a2412",
"CLM:02ff8ab5ecc9755da71f1be3"
] | [
"PMCID:PMC7385919"
] | [
"SPAN:f51c598dc2202ecb249a4e78"
] | [] | [] | {"qa_id":"QA:e530bf8f12052fda96f89899","qa_group_id":"QAG:3ddf1942a5ba6214bac862fc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Importantly, engrafted tumors exhibited the heterogenous sensitivi... |
QA:ed1b613657118480aa54a84a | QAG:7221d161e7a05f8c04aea735 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Although our RAS mutant CRC organoids showed sensitivity to dual inhibition of MEK and ERK, also this drug combination promoted cell-cycle arrest rather than cell death, questioning whether it will be sufficient for the treatment of RAS mutant CRC"? Return the original... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6627364fd1e47da0d8f06e70","quotes":["Although our RAS mutant CRC organoids showed sensit... | [
"CLM:6627364fd1e47da0d8f06e70",
"CLM:0a58aec46a1065fe9c48847b",
"CLM:d6cf25e9df24e15ceeac556a"
] | [
"PMCID:PMC5127645",
"PMID:30261425"
] | [
"SPAN:69d5b0c787468fc7945efef2",
"SPAN:d4a3832497d3396828b39d40"
] | [
"ASC2:e87b1d6b884d3b661af2a2ed"
] | [
"HYP:DCH:90312f9de861a8f28b1dc4b0"
] | {"qa_id":"QA:ed1b613657118480aa54a84a","qa_group_id":"QAG:7221d161e7a05f8c04aea735","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Although our RAS mutant CRC organoids showed sensitivity to dual i... |
QA:f511189780ff7b440ef407d0 | QAG:0a322a2ede14d7d7ce69a467 | provenance_qa | paper_evidence_availability | provenance_qa | G014 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7760698? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC7760698","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC7760698"
] | [] | [] | [] | {"qa_id":"QA:f511189780ff7b440ef407d0","qa_group_id":"QAG:0a322a2ede14d7d7ce69a467","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G014","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7760698... |
QA:f878cbe7c8065149c6be9724 | QAG:bbfc80dfd47056a76b194046 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "We also observed that c-PARP expression of CRC-166T was higher than the oxaliplatin-treated M-ORG condition than in the ORG condition ( Figure 8 C and Figure S8B )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance req... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:21bf74923e863ef83e0bda9d","quotes":["We also observed that c-PARP expression of CRC-166T was significantly higher... | [
"CLM:21bf74923e863ef83e0bda9d",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC10705195"
] | [
"SPAN:6b0a0410b49a6c4ab2775a3a"
] | [] | [] | {"qa_id":"QA:f878cbe7c8065149c6be9724","qa_group_id":"QAG:bbfc80dfd47056a76b194046","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"We also observed that c-PARP expression of CRC-166T was higher tha... |
QA:fe869bc6b39991972c5adceb | QAG:3a59189652a291a9ce02eb1d | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "Epithelial-mesenchymal Transition and Metastasis of colon Cancer Cells promoted by the Fak Pathway in Cancer-Associated Fibroblasts"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:17ac2f32c1ec792ca5f45e6c","quotes":["Epithelial-mesenchymal Transition and Metastasis of colon Cancer Cells Induc... | [
"CLM:17ac2f32c1ec792ca5f45e6c",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC8902504"
] | [
"SPAN:60ae2415a071b83d981361b8"
] | [] | [] | {"qa_id":"QA:fe869bc6b39991972c5adceb","qa_group_id":"QAG:3a59189652a291a9ce02eb1d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"Epithelial-mesenchymal Transition and Metastasis of colon Cancer C... |
QA:ff6fde2b926a720eb5c50f72 | QAG:0a85227307433580dad1caa7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "In TCGA-CRC cohort, the univariate Cox regression model revealed that the DRS was associated with prognosis of CRC patients in terms of OS ( P < 0.0001) ( Figure 6A )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:48ad4aa2bedec1ec273ee504","quotes":["The equation of DRS was finally derived: DRS = GEL (gene expression level) (... | [
"CLM:48ad4aa2bedec1ec273ee504",
"CLM:0a58aec46a1065fe9c48847b"
] | [
"PMCID:PMC9004628"
] | [
"SPAN:edd23bdbb5a4190ed4c3c2fd"
] | [] | [] | {"qa_id":"QA:ff6fde2b926a720eb5c50f72","qa_group_id":"QAG:0a85227307433580dad1caa7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"In TCGA-CRC cohort, the univariate Cox regression model revealed t... |
QA:ff8db14217f6dcf33a00c9c8 | QAG:2b62f6de6fc98977eba0d1f1 | provenance_qa | exact_evidence_retrieval | provenance_qa | G014 | en | train | Which exact source passage supports the statement "TOBis mass cytometry and Trellis single-cell screening revealed that drug promoted PTM signaling responses are PDO-specific and demonstrated that CAFs shift epithelial cells toward a slow-cycling revival stem cell fate to protect CRC cells from chemotherapy"? Return the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c35c47003f069699d7ab7f38","quotes":["TOBis mass cytometry and Trellis single-cell screening revealed\nthat drug-i... | [
"CLM:c35c47003f069699d7ab7f38",
"CLM:d5cf7f03a5e8504f09acbe5f"
] | [
"PMID:38065081"
] | [
"SPAN:b0d570f1326faf9b89c0b8ff"
] | [] | [] | {"qa_id":"QA:ff8db14217f6dcf33a00c9c8","qa_group_id":"QAG:2b62f6de6fc98977eba0d1f1","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G014","question":"Which exact source passage supports the statement \"TOBis mass cytometry and Trellis single-cell screening revealed th... |
QA:011c318458fdc056040beb1f | QAG:4d164381754230d445ae78d7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "In addition, overuse of chemotherapy led to unacceptable drug toxicity, and insufficient chemotherapy leads to recurrence. These are practical challenges, and finding more accurate biomarkers for monitoring and early detection of recurrence would be helpful"? Return th... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4f5c93171ed123d2c2bbe2db","quotes":["Most early-stage (tumor-node-metastasis [TNM] stage I–III) colorectal cancer... | [
"CLM:4f5c93171ed123d2c2bbe2db",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC9907993"
] | [
"SPAN:f2533f058b190bf09db800ee"
] | [] | [] | {"qa_id":"QA:011c318458fdc056040beb1f","qa_group_id":"QAG:4d164381754230d445ae78d7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"In addition, overuse of chemotherapy led to unacceptable drug toxi... |
QA:0bc576b0a7c79ca14a9e85df | QAG:7a819fcf559f99050b486ef7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "Several studies show that the presence of ctDNA after surgery was associated with a high risk of recurrence in patients with colorectal cancer, where the sensitivity could be 40–50% in predicting relapse"? Return the original wording with paper, Claim, and Evidence Spa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e9e3102cb96074d29f3ef81f","quotes":["Several studies show that the presence of ctDNA after surgery is associated ... | [
"CLM:e9e3102cb96074d29f3ef81f",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC8933829"
] | [
"SPAN:e1f30b0eb4bb0c74d8ff326a"
] | [] | [] | {"qa_id":"QA:0bc576b0a7c79ca14a9e85df","qa_group_id":"QAG:7a819fcf559f99050b486ef7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"Several studies show that the presence of ctDNA after surgery was ... |
QA:153482d3b7b63cb6478b31ac | QAG:4bb3aafcf2ee8422a8ac942d | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "Purpose This study aims to evaluate the ability of perioperative circulating tumor DNA (ctDNA) to predict surgical outcome and recurrence following neoadjuvant chemoradiation for locally advanced rectal cancer (LARC)"? Return the original wording with paper, Claim, and... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e911a2c710613... | [
"CLM:e911a2c710613675cfdf6dd2",
"CLM:229dfdd0872b7fad8f2b5506",
"CLM:e710bc0cfaf712bdc92abfba",
"CLM:119163482eadac8c9e9386f8",
"CLM:db4be9472583c420092f6bbc",
"CLM:9ebbde126c7621674d69d567",
"CLM:28722bea258d22ebbc25fe88",
"CLM:13ab1a21621687d03c2a4376"
] | [
"PMCID:PMC8232395",
"PMID:37992872",
"PMCID:PMC9648419",
"PMCID:PMC8834623"
] | [
"SPAN:e0aaeff0ad2b320f7229db65",
"SPAN:959c36241af1bec4fbc9fda3",
"SPAN:bc2bf1c278edfe091649ea43",
"SPAN:e312f291e8489673c8c5fa0a",
"SPAN:022ac90de79847e3992503a9",
"SPAN:b5d23fe0f66ba7b07b7597a7",
"SPAN:ebb86234894e0ad0ff02a233"
] | [
"ASC2:b48c13259f1e354a54c23043",
"ASC2:d60f8a62bd05b8bd7bc8a7c8",
"ASC2:ba69b243c7e00143ebcaffe3",
"ASC2:c0071bb25cf636674c7df9c6"
] | [
"HYP:DCH:07df11c6c55b85340628e526",
"HYP:DCH:bcda47cb549c690ff12b7c71",
"HYP:DCH:233fa0c4925e4166640878ce"
] | {"qa_id":"QA:153482d3b7b63cb6478b31ac","qa_group_id":"QAG:4bb3aafcf2ee8422a8ac942d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"Purpose This study aims to evaluate the ability of perioperative c... |
QA:17829199478d8fb20d72fbf3 | QAG:a478228f57d0be0048a96d03 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "CEA levels were increased before initiation and decreased to the normal range during the course of chemotherapy (LB-CRC-25, Figure 4 B)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:729bb148fb4ea688bd0edc59","quotes":["CEA levels were elevated before initiation and decreased to the normal range... | [
"CLM:729bb148fb4ea688bd0edc59",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC8834623"
] | [
"SPAN:7ddb4249c41d5650d3ca369a"
] | [] | [] | {"qa_id":"QA:17829199478d8fb20d72fbf3","qa_group_id":"QAG:a478228f57d0be0048a96d03","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"CEA levels were increased before initiation and decreased to the n... |
QA:17f09db6eb15323d3d5a1287 | QAG:d2af09fc4eb7ecf16beb2a46 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "9%] male) were enrolled in the study"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess the embedded target Clai... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:83c18358647c266511e81f1f","quotes":["A total of 130 patients with International Union Against Cancer stages I to ... | [
"CLM:83c18358647c266511e81f1f",
"CLM:29fd3cf8f9f161496fe05b0d"
] | [
"PMCID:PMC6512280"
] | [
"SPAN:7ba260199403f06b22638c50"
] | [] | [] | {"qa_id":"QA:17f09db6eb15323d3d5a1287","qa_group_id":"QAG:d2af09fc4eb7ecf16beb2a46","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"9%] male) were enrolled in the study\"? Return the original wordin... |
QA:1ae49ba88eceb4f7726e1bfb | QAG:750ebf77edf049428a99ca1a | provenance_qa | paper_evidence_availability | provenance_qa | G015 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:33356539? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:33356539","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:33356539"
] | [] | [] | [] | {"qa_id":"QA:1ae49ba88eceb4f7726e1bfb","qa_group_id":"QAG:750ebf77edf049428a99ca1a","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G015","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:33356539? E... |
QA:1f4021e32f21c9be9ea1d932 | QAG:055e50d565788df5641feb12 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "Circulating tumor DNA analysis detects minimal residual disease and predicted recurrence in patients with stage II colon cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporti... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e710bc0cfaf712bdc92abfba","quotes":["REFERENCES\n1. Tie J, Wang Y , Tomasetti C, et al. ... | [
"CLM:e710bc0cfaf712bdc92abfba",
"CLM:229dfdd0872b7fad8f2b5506",
"CLM:a118f799485bb93be90c4cfd"
] | [
"PMID:37992872",
"PMCID:PMC10523996"
] | [
"SPAN:959c36241af1bec4fbc9fda3",
"SPAN:cb2e9c50b10b6f0ee95f9c61"
] | [
"ASC2:5cdeb1a3fe282253527902be"
] | [
"HYP:DCH:a53dfe4380d2e1ac68a227d7"
] | {"qa_id":"QA:1f4021e32f21c9be9ea1d932","qa_group_id":"QAG:055e50d565788df5641feb12","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"Circulating tumor DNA analysis detects minimal residual disease an... |
QA:21e70c566da4ce8b5d0ce868 | QAG:d7fff81313bad48b4712d911 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "Detection of potential CRC driver gene mutations after nCRT was associated with a much worse RFS (hazard ratio [HR]: 9.29; 95% CI: 3.74 to 23.10, P < 0.001; Fig 4C )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0fb0860641c822585ffc2b74","quotes":["Detection of potential CRC driver gene mutations af... | [
"CLM:0fb0860641c822585ffc2b74",
"CLM:229dfdd0872b7fad8f2b5506",
"CLM:47c2baa4cc92e7fe13347a1f"
] | [
"PMCID:PMC8407540",
"PMCID:PMC8983807"
] | [
"SPAN:fedea72ce8b85358815bc94f",
"SPAN:03c191db52ebbe0a07d442c0"
] | [
"ASC2:8cf27883adeb886139122117"
] | [] | {"qa_id":"QA:21e70c566da4ce8b5d0ce868","qa_group_id":"QAG:d7fff81313bad48b4712d911","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"Detection of potential CRC driver gene mutations after nCRT was as... |
QA:23d688519342ed2e85decd01 | QAG:712a29fefc309e97b7069283 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "CEA levels were increased before the initiation of chemotherapy and decreased to the normal range approximately 1.5 months after ctDNA became undetectable for the first time (LB-CRC-32, Supplementary Figure S26 )"? Return the original wording with paper, Claim, and Evi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:431f460f1d7ae80b64730936","quotes":["CEA levels were elevated before the initiation of chemotherapy and decreased... | [
"CLM:431f460f1d7ae80b64730936",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC8834623"
] | [
"SPAN:983f9bf83768b7caa06fc9bf"
] | [] | [] | {"qa_id":"QA:23d688519342ed2e85decd01","qa_group_id":"QAG:712a29fefc309e97b7069283","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"CEA levels were increased before the initiation of chemotherapy an... |
QA:278f93ea6720cedd1bcad211 | QAG:d20be6abafe92af7915083e9 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "A total of 879 CRC patients were included in the 8 studies"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess th... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:eb3e83e399166868ffa95029","quotes":["A total of 879 CRC patients were included in the 8 studies."],"citations":[{... | [
"CLM:eb3e83e399166868ffa95029",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC8983807"
] | [
"SPAN:b2ba1c106ba4b544c1ed31bc"
] | [] | [] | {"qa_id":"QA:278f93ea6720cedd1bcad211","qa_group_id":"QAG:d20be6abafe92af7915083e9","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"A total of 879 CRC patients were included in the 8 studies\"? Retu... |
QA:2f27711278ddf2705a1f4721 | QAG:8c43b82a67f6daf8b37573b4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "The methylation signals of ctDNA was higher than the CRC patients than in the healthy controls"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4b63c8ae957ab55efa99d6dc","quotes":["The methylation signals of ctDNA were significantly higher in the CRC patien... | [
"CLM:4b63c8ae957ab55efa99d6dc",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC7865146"
] | [
"SPAN:55724700146eb38b8c844d68"
] | [] | [] | {"qa_id":"QA:2f27711278ddf2705a1f4721","qa_group_id":"QAG:8c43b82a67f6daf8b37573b4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"The methylation signals of ctDNA was higher than the CRC patients ... |
QA:2f4bc4836175cf5fa475007b | QAG:2ab738fa47838d1b490aac4f | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "1 Despite improved surgery, implementation of screening, and advances in treatment regimens, the 5-year mortality rate for patients with CRC remains high at approximately 40%, thereby representing a significant global health burden"? Return the original wording with pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e85662e5e2153da46005fa3d","quotes":["1 Despite improved surgery, implementation of screening, and advances in tre... | [
"CLM:e85662e5e2153da46005fa3d",
"CLM:29fd3cf8f9f161496fe05b0d"
] | [
"PMCID:PMC6512280"
] | [
"SPAN:91a3f245b9445c3fe21a155b"
] | [] | [] | {"qa_id":"QA:2f4bc4836175cf5fa475007b","qa_group_id":"QAG:2ab738fa47838d1b490aac4f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"1 Despite improved surgery, implementation of screening, and advan... |
QA:3445853b3a28dbad1c7ac15a | QAG:0ff6de2a76e8a6a023087643 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "Circulating tumor DNA analysis detects minimal residual disease and predicted recurrence in patients with stage II colon cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporti... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:31f9225d716a08deb7775bb2","quotes":["13. Tie J, Wang Y, Tomaset... | [
"CLM:31f9225d716a08deb7775bb2",
"CLM:229dfdd0872b7fad8f2b5506",
"CLM:119163482eadac8c9e9386f8",
"CLM:a118f799485bb93be90c4cfd",
"CLM:9ebbde126c7621674d69d567",
"CLM:db4be9472583c420092f6bbc"
] | [
"PMCID:PMC8407540",
"PMCID:PMC9648419",
"PMCID:PMC10523996",
"PMID:37992872"
] | [
"SPAN:86859fcabd21187d92d44db3",
"SPAN:bc2bf1c278edfe091649ea43",
"SPAN:022ac90de79847e3992503a9",
"SPAN:cb2e9c50b10b6f0ee95f9c61",
"SPAN:e312f291e8489673c8c5fa0a"
] | [
"ASC2:cc590080a43143dca9649e89",
"ASC2:c132ce43af6390f2d10dea8f",
"ASC2:c80ff42c6782abf03ce13859"
] | [
"HYP:DCH:43e90159d4e19ea68eb3a090",
"HYP:DCH:23b735767c3417ebfa72737e"
] | {"qa_id":"QA:3445853b3a28dbad1c7ac15a","qa_group_id":"QAG:0ff6de2a76e8a6a023087643","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"Circulating tumor DNA analysis detects minimal residual disease an... |
QA:3716360968e1ae54f32d7ca6 | QAG:7a6405a23edcfa0db1e3ada8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G015 | en | train | Which exact source passage supports the statement "In 2016, the Epi ProColon biomarker assay detecting SEPT9 methylation received FDA approval as a CRC screening test"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage w... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:16b9222662d59ebea0beeaac","quotes":["In 2016, the Epi ProColon biomarker assay detecting SEPT9 methylation receiv... | [
"CLM:16b9222662d59ebea0beeaac",
"CLM:229dfdd0872b7fad8f2b5506"
] | [
"PMCID:PMC9101623"
] | [
"SPAN:514f60699322427cbb4adaac"
] | [] | [] | {"qa_id":"QA:3716360968e1ae54f32d7ca6","qa_group_id":"QAG:7a6405a23edcfa0db1e3ada8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G015","question":"Which exact source passage supports the statement \"In 2016, the Epi ProColon biomarker assay detecting SEPT9 methylat... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.